Acta Haematol. 2024;147(2):229-246. doi: 10.1159/000536152. Epub 2024 Feb 16.
PMID:38228114
Single-cell epigenetic and clonal analysis decodes disease progression in pediatric acute myeloid leukemia.
Cui B, Ai L, Lei M, Duan Y, Tang C, Zhang J, Gao Y, Li X, Zhu C, Zhang Y, Zhu X, Isobe T, Yang W, Göttgens B, Zhu P.
Blood. 2025 Mar 13;145(11):1211-1224. doi: 10.1182/blood.2024025618.
PMID:39661948
Measurable Residual Disease and Clonal Evolution in Acute Myeloid Leukemia from Diagnosis to Post-Transplant Follow-Up: The Role of Next-Generation Sequencing.
Sperotto A, Bochicchio MT, Simonetti G, Buccisano F, Peccatori J, Piemontese S, Calistri E, Ciotti G, Pierdomenico E, De Marchi R, Ciceri F, Gottardi M.
Biomedicines. 2023 Jan 26;11(2):359. doi: 10.3390/biomedicines11020359.
PMID:36830896
Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management.
Patnaik MM, Tefferi A.
Am J Hematol. 2024 Jun;99(6):1142-1165. doi: 10.1002/ajh.27271. Epub 2024 Mar 7.
PMID:38450850
Clonal hematopoiesis and measurable residual disease assessment in acute myeloid leukemia.
Hasserjian RP, Steensma DP, Graubert TA, Ebert BL.
Blood. 2020 May 14;135(20):1729-1738. doi: 10.1182/blood.2019004770.
PMID:32232484
Clonal haematopoiesis and dysregulation of the immune system.